Researchmoz Global Pvt. Ltd.

China Human Vaccine Industry Report, 2015-2018 Market Research Share

Most up-to-date research on "China Human Vaccine Industry Report, 2015-2018" to its huge collection of research reports.

 

Albany, NY -- (SBWIRE) -- 03/30/2015 -- A vaccine is a preventive biological product for human use that prevents and controls the occurrence and prevalence of infectious diseases, so the demand for such products is relatively rigid. Due to suspected deaths stemming from vaccination and some companies' (such as Shenzhen Kangtai, Tiantan Biological and Dalian Hissen) production halts of some products because of their failure to pass new GMP certification, China's human vaccine lot release volume in 2014 declined by 2.4% year on year to 791 million doses.

Browse Detail Report With TOC
http://www.researchmoz.us/china-human-vaccine-industry-report-2015-2018-report.html

Affected by China's less-developed economy, existing national vaccine prevention policies and people's awareness of epidemic prevention, free EPI vaccines prevail in China with a share of about 80% in the total lot release volume. Chinese free human vaccine market is still dominated by Beijing Tiantan Biological Products, Chengdu Institute of Biological Products Co., Ltd., Shanghai Institute of Biological Products Co., Ltd., Lanzhou Institute of Biological Products Co., Ltd., Wuhan Institute of Biological Products Co., Ltd., Changchun Institute of Biological Products Co., Ltd., Institute of Medical Biology under Chinese Academy of Medical Sciences and other state-owned enterprises, but their market shares are falling. In 2014, the EPI vaccine lot release volume of Chinese state-owned enterprises accounted for 72%, down 6.5 percentage points compared with the previous year.

Request for Sample Report
http://www.researchmoz.com/enquiry.php?type=sample&repid=255822

However, as China gradually relaxes control over the vaccine market, private companies and foreign players are emerging in market segments of extra EPI vaccine, with their proportions increasing constantly, accounting for 80% in terms of lot release volume. Moreover, private and foreign brands hold a dominant position in the markets of Haemophilus influenza B (Hib), human rabies vaccine, varicella vaccine, and influenza vaccine, together making up 91.9%, 83.6%, 86.5%, and 69.5% in terms of lot release volume in 2014.

For Market Research Latest Reports Visit
http://www.researchmoz.us/latest-report.html

Being bullish about China's demand for human vaccines and exports, many vaccine producers scale up efforts in vaccine R&D or expand capacity, such as Walvax Biotechnology. By early 2015, GMP on-site certification had been carried out for the company's Diphtheria-tetanus-acellular pertussis combined vaccine adsorbed; HPV bivalent (types 16 and 18) vaccine and DTaP/Hib had made their way into clinical trials; the company is applying registration for meningococcal polysaccharide vaccine (Group A/C/Y/W 135) and other vaccines in Nigeria, Chile, Peru, Thailand, and India.

Related Reports
Global Influenza Vaccine Industry 2015 Market Research Report
(http://www.researchmoz.us/global-influenza-vaccine-industry-2015-market-research-report-report.html)
For overview analysis, the report introduces Influenza Vaccine basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the report analyzes Influenza Vaccine markets in China and other countries or regions (such as US, Europe, Japan,...

Global Hepatitis B Vaccine Industry 2014 Market Research Report
(http://www.researchmoz.us/global-hepatitis-b-vaccine-industry-2014-market-research-report-report.html)
2014 Global Hepatitis B Vaccine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Hepatitis B Vaccine industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Hepatitis B Vaccine basics: definitions,...

Browse All Reports in Vaccines Category
http://www.researchmoz.us/vaccines-market-reports-79.html

About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Email: sales@researchmoz.us